G1SecL05: Difference between revisions

No edit summary
Line 3: Line 3:
[[Image:1FJ1 Chain E.jpg|300px|right|thumb| 1FJ1 Chain E]]
[[Image:1FJ1 Chain E.jpg|300px|right|thumb| 1FJ1 Chain E]]


= Table of Contents=
CONTENT
*'''1. Background '''
*'''2. Development of the recombinant vaccine
*'''3. Introduction to the LA-2 fab complex
*'''4. Binding affinitity and interactions in the LA-2 fab complex'''
*'''5. Structural Defects in the vaccine'''
*'''6. Discussion'''


'''Background'''
1. Background


Lyme disease, discovered in 1975, is a vector- borne disease caused by the inoculation of spirochete borrelia into the skin by members of hard bodied ticks of the family Ixodidae. Symptoms include arthritis at major joints, neurological problems such as reduced memory and poor ability to concentrate, and characteristic lesions erythema migans, more commonly known as the bull’s eye rash. A major outer surface membrane protein of Borrelia, ospA, plays a key role in immunity against Lyme disease through its binding to the antibody LA-2 fab.
2. Introduction to the fab complex, LA-2 , some history, what is it etc?


''' Development of the recombinant vaccine '''
3. Structural capabilities – loops – loop 1, loop 2, loop 3 brief overview s and exactly how does the ospA bind to the LA-2
 
4. Variability – highlight Ala 208, trp 216, a hvl 217 -237 – basically our stories , a couple of sentences on each.
 
Background
 
Lyme disease, discovered in 1975<ref>PMID: 17160599</ref>, is a vector--borne disease caused by the inoculation of spirochete borrelia into the skin by members of hard bodied ticks of the family Ixodidae. Symptoms include arthritis at major joints, neurological problems such as reduced memory and poor ability to concentrate, and characteristic lesions erythema migans, more commonly known as the bull’s eye rash. A major outer surface membrane protein of Borrelia, ospA, plays a key role in immunity against Lyme disease through its binding to the antibody LA-2 fab.
 
Introduction to the LA-2 OspA


<Structure load='1fj1' size='500' frame='true' align='right' caption='Insert caption here' scene='Insert optional scene name here' />
<Structure load='1fj1' size='500' frame='true' align='right' caption='Insert caption here' scene='Insert optional scene name here' />
Line 27: Line 29:


<scene name='G1SecL05/1fj1-condensed/2'>Composite Three variable regions highlights, Tryptophan 216 - Blue, Alanine 208 - Purple, Highly Variable LA-2 Fab + OspA conjunction - Red</scene>
<scene name='G1SecL05/1fj1-condensed/2'>Composite Three variable regions highlights, Tryptophan 216 - Blue, Alanine 208 - Purple, Highly Variable LA-2 Fab + OspA conjunction - Red</scene>
==References==
<references />

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Moazzam Khan, Supriya Kannan, Rubab Farhat, Noopoor Akruwala, Michal Harel